We performed immunohistochemistory using domain-specific phospho-Smad3 Abs in liver biopsy specimens from 30 NASH patients representing different fibrotic stages and 20 chronically infected hepatitis C patients as controls. Here, SMAD3 is linked to metabolic dysfunction-associated steatohepatitis.